Navigation Links
Sunridge Moves Forward to Open Company Owned Clinics
Date:1/13/2011

FOUNTAIN HILLS, Ariz., Jan. 13, 2011 /PRNewswire/ -- Sunridge International (OTC Bulletin Board: SNDZ), announced today that it plans to open company owned glaucoma clinics for the use of its patented treatment Pneumatic Trabeculoplasty (PNT).  

As a manufacturer, Sunridge currently relies on its distributor network for sales.  Though the company is in the process of expanding its distributor network, it is still reliant on others to provide profitability for the company.  It is the company's intent to take advantage of its patented procedure by initiating glaucoma clinics under its direct control.  By doing so, Sunridge can capitalize not only on the sales of its equipment and disposable product line to others, but also a direct revenue source from our clinics for the medical treatment itself.  

Sunridge is currently raising money to open its first clinic.  Based on past experience our projections for the clinic would indicate that it would be cash flow positive by its fourth month of operation.  Once successful with the first clinic, Sunridge intends to raise capital for the rapid expansion of additional company owned clinics.  This new direction in the company's business plan allows us to take direct charge of our future and accelerate profitability for the company.

Glaucoma is the second leading cause of blindness, affecting over 70 million people worldwide. PNT has been proven (through studies completed over the last 10 yrs) to be a safe, effective, non-invasive and a cost effective alternative for treatment for glaucoma and ocular hypertension. The 2-minute treatment has been developed, patented, and distributed by Sunridge International, wholly owned subsidiary, Ophthalmic International www.oi-pnt.com.CONTACT:Jeff Smith Sunridge InternationalT:  +1-480-837-6165e-mail: '/>"/>

SOURCE Sunridge International
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sunridge Middle East Distributor to Begin Clinical Trials Necessary for Reimbursement
2. Sunridge Schedules Public Conference Call
3. Sunridge Receives Reorder on $4 Million Indian Contract
4. Sunridge Advances its PNT Glaucoma Treatment Throughout China
5. Sunridge to Introduce Their PNT Treatment for Glaucoma to Medical Personnel in India
6. Sunridge Ships First Order to the Middle East
7. Sunridge Schedules European Meetings
8. Sunridge Announces Marketing Roll Out of PNT in the Dominican Republic
9. Sinovacs Stock Exchange Listing Moves to NASDAQ Global Select Market
10. Unilife Corporation Moves into New State-of-the-Art Manufacturing Facility and Global Headquarters
11. Crescent Healthcare Moves to CPR+ as Its Home Infusion Software Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , Aug. 28, 2015  Delays in ... projects can slow down the decision-making process, resulting ... therefore, absolutely critical for biopharmaceutical companies to develop ... approval process for quicker and more meaningful insights. ... Best Practices, LLC, nearly three-quarters of benchmarked study ...
(Date:8/28/2015)... , Aug. 28, 2015 ... addition of the "Investigation Report on China,s Bevacizumab ... Developed by Roche under the trade name of Avastin, ... world. In Feb.26, 2010, it was approved by CFDA ... in China all come from ...
(Date:8/28/2015)... 2015 Patterson Medical, formerly the medical ... ), is now an independent company with today,s ... Medical by Madison Dearborn Partners (MDP).  ... a transition period before rebranding as the world,s ... products.  With the focused resources and expertise of ...
Breaking Medicine Technology:Expediting the Pharmaceutical Market Research Process for Faster Insights 2Investigation Report on China's Bevacizumab Market 2015-2019 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 3
... DIEGO, Feb. 3, 2011 Ceregene, Inc., a biopharmaceutical ... and dosing in its CERE-120 (AAV2-neurturin) Phase 2b multi-center, ... was initiated in October 2010 and all 11 centers ...  These sites are among the best movement disorders centers ...
... 3, 2011 Corium International, Inc., a privately-held ... appointment of Dr. Bhaskar Chaudhuri and David L. ... most recently served as President of Valeant Pharmaceuticals ... Officer of Dow Pharmaceutical Services, Inc.  Mr. Greenwood ...
Cached Medicine Technology:Ceregene Advances Phase 2b CERE-120 (AAV2-neurturin) Trial in Parkinson's Disease 2Ceregene Advances Phase 2b CERE-120 (AAV2-neurturin) Trial in Parkinson's Disease 3Ceregene Advances Phase 2b CERE-120 (AAV2-neurturin) Trial in Parkinson's Disease 4Ceregene Advances Phase 2b CERE-120 (AAV2-neurturin) Trial in Parkinson's Disease 5Corium International Adds Dr. Bhaskar Chaudhuri and David Greenwood to Board of Directors 2Corium International Adds Dr. Bhaskar Chaudhuri and David Greenwood to Board of Directors 3
(Date:8/28/2015)... ... 2015 , ... Approximately 2,000 United Methodists are expected to ... children, a thank you to the many creative and generous ways in which ... Methodist initiative to end malaria deaths. , The Columbus Zoo and Aquarium event, ...
(Date:8/28/2015)... ... August 28, 2015 , ... An article published August 19th by ... has gone through to open a pizzeria in Westchester. Mr. LaRocco was aware from ... several months, but the current process, having already gone on for over a year, ...
(Date:8/28/2015)... ... August 28, 2015 , ... For Dallas, the time is nearing for the ... USPI Tenet Health. , The American Heart Association hosts their well-known Heart Walk to ... that together, a difference can be made. Walkers can participate in the cause and ...
(Date:8/28/2015)... ... ... As reported by Medical Daily on August 22 , Cellfina, a ... for two years, the longest of any cellulite reduction system currently on the market. ... effective solution for their cellulite, according to Dr. Robert Weiss, director of the premier ...
(Date:8/28/2015)... ... August 28, 2015 , ... On May 30th, 2015, ... as sponsor of the “Music With A Mission” benefit concert in Mendon, IL. Held ... was to raise money to support music education programs in the underfunded local school ...
Breaking Medicine News(10 mins):Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 3Health News:Article on Building Approval Process for LA Business Highlights the Need for a Bridge Between Businesses and City Officials, says Fire Protection Group Inc. 2Health News:North Central Surgical Center’s Subsidiary Participates in Walk 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3Health News:New Video Released on "Music With A Mission" Benefit Concert Headlining Artist Cadillac Three & Best Drug Rehabilitation 2
... 16, 2009 A new study published in ... almost twice as high in people with epilepsy compared ... minorities have seven times the odds of depression in ... show that 40 percent of depressed respondents with epilepsy ...
... test capable of confirming or ruling out Alzheimer,s disease ... University of Pennsylvania School of Medicine. By measuring cerebrospinal ... hallmarks amyloid beta42 peptide and tau protein ... impairment would convert to Alzheimer,s disease over time. Researchers ...
... proudly announces that the Peyton Manning Children,s Hospital at ... 6th Annual Talk Walk Run 2009 fundraiser benefiting deaf ... more than 30 years, Hear Indiana has helped children ... members of society," said R. Christopher Miyamoto, pediatric ENT ...
... Will Deliver Educational Training and Professional Certification ... PulseLearning, a leading Ireland-based provider of ... to develop customized eLearning and certification programs ... Casualty Underwriters and the Insurance Institute of ...
... 16 OrbusNeich Medical, Inc. ("Orbus" or the "Company"), ... devices for the treatment of vascular diseases, today announced ... Corporation ("BSC"). The lawsuit, filed in the United ... asserts claims against BSC for patent infringement, breach of ...
... a novel genetic technology that covers up genetic errors, ... Health have developed a successful treatment for dogs with ... and ultimately fatal, muscle disease. , The technology, known ... as molecular "patches." These patches cover up mutant DNA ...
Cached Medicine News:Health News:Depression twice as likely in seizure sufferers 2Health News:Penn Medicine pathologists pioneer biomarker test to diagnose or rule out Alzheimer's disease 2Health News:Penn Medicine pathologists pioneer biomarker test to diagnose or rule out Alzheimer's disease 3Health News:Peyton Manning Children's Hospital at St. Vincent Will Serve As Lead Sponsor of Hear Indiana's 6th Annual Talk Walk Run 2009 2Health News:Ireland's PulseLearning Inks Agreement With Leading U.S. Insurance Industry Association 2Health News:OrbusNeich Files Patent Infringement Lawsuit Against Boston Scientific 2Health News:OrbusNeich Files Patent Infringement Lawsuit Against Boston Scientific 3Health News:Researchers develop DNA 'patch' for canine form of muscular dystrophy 2Health News:Researchers develop DNA 'patch' for canine form of muscular dystrophy 3
The IgA in vitro diagnostic enzyme immunoassay is intended for the qualitative detection of anti-human tTG IgA antibodies in human serum as an aid in the diagnosis of CD....
...
... The FIDIS system and its ... simultaneously and on the same sample, ... dedicated to all types of laboratories ... than today their daily routine, as ...
The PICO50 is used for arterial line sampling....
Medicine Products: